NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 77 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $43,651 | +351.9% | 52,591 | +281.1% | 0.00% | – |
Q1 2023 | $9,660 | -93.7% | 13,800 | -90.7% | 0.00% | – |
Q2 2022 | $153,000 | -13.6% | 148,402 | +58.5% | 0.00% | – |
Q1 2022 | $177,000 | -67.0% | 93,640 | -15.8% | 0.00% | – |
Q4 2021 | $536,000 | +232.9% | 111,174 | +397.1% | 0.00% | – |
Q3 2021 | $161,000 | -91.1% | 22,366 | -88.5% | 0.00% | – |
Q2 2021 | $1,802,000 | -26.7% | 195,262 | -2.2% | 0.00% | – |
Q1 2021 | $2,458,000 | -10.6% | 199,631 | +2.5% | 0.00% | – |
Q4 2020 | $2,748,000 | -37.2% | 194,856 | -46.6% | 0.00% | -100.0% |
Q3 2020 | $4,377,000 | +280.3% | 364,759 | +426.1% | 0.00% | – |
Q2 2020 | $1,151,000 | -7.5% | 69,333 | -36.6% | 0.00% | – |
Q1 2020 | $1,244,000 | – | 109,317 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |